Pharmaceutical ResearchNews - Page 4

EU project to develop a bio-artificial lab-grown pancreas

Scientists from the EU-funded VANGUARD project have received €6,844,625 to develop a bio-artificial lab-grown pancreas. By developing an artificial lab-grown pancreas, the VANGUARD project aims...

The social and economic consequences of antimicrobial resistance

Dr Jochen Salber, Head of the Department of Experimental Surgery at University Medical Centre Knappschaftskrankenhaus Bochum, discusses the challenges posed by antimicrobial resistance. At a...

How successful is the new wave of COVID-19 technologies?

Scientists have developed a multitude of new innovative COVID-19 technologies – but which can successfully aid the global recovery from the recent pandemic? Since the...

Innovative bioscaffold to promote healing and tissue regeneration

Next generation extracellular matrix biomaterials promote healing – Is human tissue regeneration within reach? Unlike less-developed species such as the axolotl and zebra fish, the...

Modifying calcium phosphate-based materials for bone repair

Dr Christophe Drouet and Dr David Grossin explain the relevance of calcium phosphate-based materials for bone repair and nanomedicine. For decades, nature has inspired civilisations...

The key role played by pharmacies, according to the citizens

Cittadinanzattiva discusses the findings of a recent report into the role played by pharmacies in Italy as a part of the move towards ‘pharmacies...

Assessing decades of research to further integrate precision medicine

Evolutionary biologists from McMaster University have reviewed decades of research in the hopes of understanding why precision medicine has not been fully integrated into...

Regenerative medicine: repairing fundamental issues

Recent European analysis has demonstrated that the European clinical trial landscape for regenerative medicine is falling behind. The Alliance for Regenerative Medicine (ARM) is an...

Connecting communities in medicinal chemistry and chemical biology

European Federation for Medicinal Chemistry speaks to TIP about how medicinal chemistry is at the forefront of recent breakthroughs in therapies that address unmet medical...

Revolutionising cancer immunotherapy with BiTEs and CAR T cells

Did you know that T cell recruiting immunotherapies with BiTEs and CAR T cells could revolutionise cancer immunotherapy? In the future, various immunotherapeutic treatment platforms...

CUTISS on the challenges and opportunities in regenerative therapy

CUTISS’ CEO Dr Daniela Marino explains the current challenges and opportunities in regenerative therapy for burn victims and patients with skin defects. Skin is the...

New tech to reduce cost and carbon footprint of anaesthesia

An award winning innovation within the anaesthesia industry has been launched at the Royal Cornwall Hospital, after reports that it reduces both cost and...

Bioengineered bacteria to protect against colony collapse

Scientists from the University of Texas at Austin have developed a new strategy, using engineered bacteria, to protect honeybees from colony collapse disorder. According to...

Novel therapeutics using mesenchymal stem cells for treatment

The Center for Stem Cell Research and Regenerative Medicine performs research using mesenchymal stem/stromal cells for treatment via cell therapies and  tissue engineering strategies. Adult...

Immunology research: let’s talk about vaccines

The British Society for Immunology’s Chief Executive tells us about creating a healthy environment for immunology research. The British Society for Immunology’s mission is to...

Preclinical drug development for childhood cancers

Research at Greehey Children’s Cancer Research Institute (Greehey CCRI) has been at the forefront of improving relevant preclinical models for developing new therapeutics. Cancer in...

Dr Ann Moen on the global influenza strategy

Dr Ann Moen, Chief of the WHO’s Influenza Preparedness & Response Unit (IPR), explains the importance of their latest strategy: the Global Influenza Strategy...

Chronic hepatitis B remains a global health problem

Re-designing the hepatitis B vaccine: helping WHO achieve one of the 2030 elimination targets as Chronic hepatitis B (CHB) remains a global health problem. According...

Molecular precision medicine: the effectiveness of personalised prevention programmes

PRECISION MEDICINE ALLIANCE spoke to Innovation News Network about the importance of precision medicine and individual therapies. Precision medicine can be described as a form...

The launch of the START project: how Diamond Light Source is contributing to global research

Innovation News Network met with Diamond Light Source’s Professor Laurent Chapon and Professor Dave Stuart at the launch of the START project to discuss...

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd